Countdown to Next Report: Special Report with Game-Changing Potential Coming Your Way

Dear , Tomorrow, I'll be unveiling my latest Sniper Report pick.  It's your chance to lock in what I believe— will be an easy 50% gain. I'm calling it the #1 M&A trade of 2020. But don't let that intimidate you.  There's nothing complicated about it. In fact, I am just going to flat out buy the stock.  I want in, and I don't have time to mess around with options. Hundreds of new members will be receiving my latest Sniper pick. But according to my records—you won't be.  I'm not sure why though.  I've made a career out of identifying catalysts and taking advantage of them.  In fact, I've made over $1M in trading profits this year alone—and May just started.   I've done my due diligence on this play. I read through analyst reports, examined it on my Bloomberg terminal, and have even found out what the major players involved in the deal had to say.  Volkswagen's CFO was quoted on record as saying this about the deal: "In terms of XXX, no, we've not pulled the deal. We still believe it is strategically a good idea." I've even knocked the price of the Sniper Report down by 70% I could have easily kept this trade idea to myself, but I'm so confident in it, that I wanted to share it with my subscribers.  This is just the fifth time in two years I've released a special Sniper Report. And one that I believe will go down in history as a no-brainer.  But you're going to miss it.  That is unless you join the Sniper Report. Remember, your subscription doesn't only give you access to this trade, but also 12-months of my highest conviction catalyst swing trade ideas.  Ideas that I put my own capital behind.  You have till midnight to decide. Wait a minute longer and prepare to pay 3 times the price.  Hold off more, and you miss my M&A trade of the year. Months from now you'll be torturing yourself… Playing the woulda, coulda, shoulda game.  I didn't reach $8M in trading profits by sitting on the sidelines.  When the market gives me a favorable opportunity I take it.  That's how I've built my wealth.  Of course, I can't place trades for you.  It's on you to decide. You've got only a few hours left. Kyle Dennis RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 Click Here to stop receiving emails from kyle@biotechbreakouts.com Unsubscribe from all RagingBull emails Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative's own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.